• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C3肾小球病的诊断问题

Diagnostic Problems in C3 Glomerulopathy.

作者信息

Niepolski Leszek, Czekała Anna, Seget-Dubaniewicz Monika, Frydrychowicz Magdalena, Talarska-Markiewicz Patrycja, Kowalska Angelika, Szmelter Jagoda, Salwa-Żurawska Wiesława, Sirek Tomasz, Sobański Dawid, Grabarek Beniamin Oskar, Żurawski Jakub

机构信息

Department of Physiology, Poznan University of Medical Sciences, 60-567 Poznan, Poland.

Department of Clinical Pathology, Poznan University of Medical Sciences, 60-567 Poznan, Poland.

出版信息

Biomedicines. 2023 Apr 5;11(4):1101. doi: 10.3390/biomedicines11041101.

DOI:10.3390/biomedicines11041101
PMID:37189718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10135645/
Abstract

BACKGROUND

C3 glomerulopathies (C3GN) are a group of rare kidney diseases associated with impaired complement regulation. The effects of this disease include the accumulation of complement C3 in the kidneys. Based on the clinical data, as well as light, fluorescence, and electron microscopy results, the diagnoses were verified. The study group consisted of biopsy specimens, which were obtained from 332 patients who were diagnosed with C3 glomerulopathy. In all cases, histopathological examinations were performed; deposits of complement C3 and C1q components, as well as the immunoglobulins IgA, IgG, and IgM, were identified using immunofluorescence. Furthermore, electron microscopy was also performed.

RESULTS

The histopathological examination results presented cases of C3GN (n = 111) and dense deposit disease (DDD; n = 17). The non-classified (NC) group was the most numerous (n = 204). The lack of classification was due to the poor severity of the lesions, even on the electron microscopic examination or in the presence of intense sclerotic lesions.

CONCLUSIONS

In cases of suspected C3 glomerulopathies, we believe an electron microscopy examination is necessary. This examination is beneficial in mild-to-extremely-severe cases of this glomerulopathy, where the lesions are barely discernible when using immunofluorescence microscopy.

摘要

背景

C3肾小球病(C3GN)是一组与补体调节受损相关的罕见肾脏疾病。该疾病的影响包括补体C3在肾脏中的蓄积。基于临床数据以及光镜、荧光镜和电镜检查结果,进行了诊断验证。研究组由活检标本组成,这些标本取自332例被诊断为C3肾小球病的患者。所有病例均进行了组织病理学检查;使用免疫荧光法鉴定了补体C3和C1q成分以及免疫球蛋白IgA、IgG和IgM的沉积。此外,还进行了电镜检查。

结果

组织病理学检查结果显示有C3GN病例(n = 111)和致密沉积物病(DDD;n = 17)。未分类(NC)组数量最多(n = 204)。缺乏分类是由于病变严重程度较低,即使在电镜检查时或存在严重硬化性病变的情况下也是如此。

结论

在疑似C3肾小球病的病例中,我们认为电镜检查是必要的。该检查对于这种肾小球病的轻度至极重度病例有益,在这些病例中,使用免疫荧光显微镜检查时病变几乎难以辨别。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/c47217a8b11b/biomedicines-11-01101-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/fd8e27ab05fc/biomedicines-11-01101-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/7ec86d6fe2eb/biomedicines-11-01101-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/41f5ac6c117b/biomedicines-11-01101-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/4885e3ce952d/biomedicines-11-01101-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/802ce08939ec/biomedicines-11-01101-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/8983d41b525f/biomedicines-11-01101-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/cf8808b8222e/biomedicines-11-01101-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/c47217a8b11b/biomedicines-11-01101-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/fd8e27ab05fc/biomedicines-11-01101-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/7ec86d6fe2eb/biomedicines-11-01101-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/41f5ac6c117b/biomedicines-11-01101-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/4885e3ce952d/biomedicines-11-01101-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/802ce08939ec/biomedicines-11-01101-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/8983d41b525f/biomedicines-11-01101-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/cf8808b8222e/biomedicines-11-01101-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61b2/10135645/c47217a8b11b/biomedicines-11-01101-g008.jpg

相似文献

1
Diagnostic Problems in C3 Glomerulopathy.C3肾小球病的诊断问题
Biomedicines. 2023 Apr 5;11(4):1101. doi: 10.3390/biomedicines11041101.
2
Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy.载脂蛋白 E 在致密沉积物中富集,是 C3 肾小球病中致密沉积物病的标志物。
Kidney Int. 2024 May;105(5):1077-1087. doi: 10.1016/j.kint.2024.02.013. Epub 2024 Mar 4.
3
Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.C3肾小球病的临床病理谱——一项来自印度的经验
Diagn Pathol. 2015 Mar 17;10:6. doi: 10.1186/s13000-015-0233-0.
4
C3 glomerulopathy: clinicopathologic features and predictors of outcome.C3肾小球病:临床病理特征及预后预测因素
Clin J Am Soc Nephrol. 2014 Jan;9(1):46-53. doi: 10.2215/CJN.04700513. Epub 2013 Oct 31.
5
C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.在一项美国大型 C3 肾小球病患者队列中,C3 肾小球肾炎和致密物沉积病具有相似的疾病进程。
Kidney Int. 2018 Apr;93(4):977-985. doi: 10.1016/j.kint.2017.10.022. Epub 2018 Jan 6.
6
Defining the complement biomarker profile of C3 glomerulopathy.定义C3肾小球病的补体生物标志物谱。
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1876-82. doi: 10.2215/CJN.01820214. Epub 2014 Oct 23.
7
C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis.C3肾小球病:致密物沉积病和C3肾小球肾炎。
Front Med (Lausanne). 2023 Nov 24;10:1289812. doi: 10.3389/fmed.2023.1289812. eCollection 2023.
8
Kidney Transplantation in C3 Glomerulopathy: A Case Series.C3 肾小球病的肾移植:病例系列。
Am J Kidney Dis. 2019 Mar;73(3):316-323. doi: 10.1053/j.ajkd.2018.09.002. Epub 2018 Nov 7.
9
Glomerular C4d Staining Does Not Exclude a C3 Glomerulopathy.肾小球C4d染色不能排除C3肾小球病。
Kidney Int Rep. 2019 Feb 13;4(5):698-709. doi: 10.1016/j.ekir.2019.02.006. eCollection 2019 May.
10
Characterization of C3 in C3 glomerulopathy.补体 C3 在 C3 肾小球疾病中的特征。
Nephrol Dial Transplant. 2017 Mar 1;32(3):459-465. doi: 10.1093/ndt/gfw290.

引用本文的文献

1
Low C3 in a 4-month-old baby: is it a problem?一名4个月大婴儿的C3水平低:这是个问题吗?
Pediatr Nephrol. 2024 May;39(5):1427-1428. doi: 10.1007/s00467-023-06228-x. Epub 2023 Nov 24.

本文引用的文献

1
The lupus nephritis classification: lost in translation.狼疮肾炎分类:翻译有误。
Curr Opin Nephrol Hypertens. 2023 Mar 1;32(2):199-203. doi: 10.1097/MNH.0000000000000865. Epub 2022 Dec 23.
2
Glomerulonephritis: immunopathogenesis and immunotherapy.肾小球肾炎:免疫发病机制与免疫治疗。
Nat Rev Immunol. 2023 Jul;23(7):453-471. doi: 10.1038/s41577-022-00816-y. Epub 2023 Jan 12.
3
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies.
伴有 C3G 或 IC-MPGN 的患者接受因子 D 抑制剂 Danicopan 治疗的临床结局:两项 2 期研究的最终结果。
Am J Nephrol. 2022;53(10):687-700. doi: 10.1159/000527167. Epub 2022 Nov 24.
4
Acute glomerulonephritis.急性肾小球肾炎
Lancet. 2022 Apr 23;399(10335):1646-1663. doi: 10.1016/S0140-6736(22)00461-5.
5
Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment.膜增生性肾小球肾炎:不再是同一种疾病,可能需要非常不同的治疗。
Nephrol Dial Transplant. 2023 Feb 13;38(2):283-290. doi: 10.1093/ndt/gfab281.
6
Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry.日本免疫复合物性膜增生性肾小球肾炎和 C3 肾小球肾炎的人口统计学、临床特征和治疗结果:日本肾活检登记处数据的回顾性分析。
PLoS One. 2021 Sep 14;16(9):e0257397. doi: 10.1371/journal.pone.0257397. eCollection 2021.
7
Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties.C3肾小球病和Ig介导的膜增生性肾小球肾炎的实际管理:事实与不确定性
Kidney Int. 2020 Nov;98(5):1135-1148. doi: 10.1016/j.kint.2020.05.053. Epub 2020 Jul 3.
8
[C3 glomerulopathy and MPGN - current classification].[C3肾小球病与膜增生性肾小球肾炎 - 当前分类]
Dtsch Med Wochenschr. 2020 Feb;145(4):232-239. doi: 10.1055/a-0974-8418. Epub 2020 Feb 18.
9
A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease.C3 肾小球病:一种罕见的肾脏疾病的叙述性综述。
Int J Mol Sci. 2020 Jan 14;21(2):525. doi: 10.3390/ijms21020525.
10
Mechanisms of haemolysis-induced kidney injury.溶血导致肾损伤的机制。
Nat Rev Nephrol. 2019 Nov;15(11):671-692. doi: 10.1038/s41581-019-0181-0. Epub 2019 Aug 27.